Results 181 to 190 of about 951,869 (260)
Natural Products with Potent Antimycobacterial Activity (2000-2024): A Review. [PDF]
Paulos B, Bisrat D, Yeshak MY, Asres K.
europepmc +1 more source
Antimicrobial Resistance in <i>Rhodococcus equi</i> and the Promise of Synergistic Therapies. [PDF]
Javadimarand F +9 more
europepmc +1 more source
Extrapulmonary Tuberculosis in the Bone Marrow: A Case of Pancytopenia and Chronic Corticosteroid Use. [PDF]
Salehi SA +5 more
europepmc +1 more source
Atypical ulcerative cutaneous tuberculosis revealing disseminated mycobacterial infection: case report with diagnostic and therapeutic challenges. [PDF]
Vita S +13 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Pharmaceutical Biotechnology, 2022
BACKGROUND Sir Alexander Fleming accidentally discovered antibiotics in 1928. Antibiotics have played a significant role in treating infectious diseases.
S. Prasad +3 more
semanticscholar +1 more source
BACKGROUND Sir Alexander Fleming accidentally discovered antibiotics in 1928. Antibiotics have played a significant role in treating infectious diseases.
S. Prasad +3 more
semanticscholar +1 more source
Total synthesis of an antitubercular lactone antibiotic, (+)-tubelactomicin A
Tetrahedron Letters, 2006AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Seijiro Hosokawa +3 more
openaire +1 more source
Journal of Inorganic Biochemistry, 2012
Capreomycin is an important therapeutic agent having intriguing and diverse molecular features. Its polypeptidic structure rich in nitrogen donors makes the drug a promising chelating agent for a number of transition metal ions, especially for copper(II).
Stokowa K. +5 more
openaire +3 more sources
Capreomycin is an important therapeutic agent having intriguing and diverse molecular features. Its polypeptidic structure rich in nitrogen donors makes the drug a promising chelating agent for a number of transition metal ions, especially for copper(II).
Stokowa K. +5 more
openaire +3 more sources

